Research Article: Radiotherapy Use in Muscle-Invasive Bladder Cancer: Review of the Guidelines and Impact of Increased Awareness in Patient Referral at a Tertiary Center in Belgium
Introduction:
Neo-adjuvant chemotherapy, followed by surgery, and in case of high-risk residual disease, adjuvant immunotherapy, is recognised as standard of care treatment for muscle-invasive bladder cancer (MIBC). The role of radiotherapy (RT) in the management of MIBC is more frequently debated. Despite being one of the cancers with the most frequent evidence-based indications for RT, its actual utilization in the treatment of bladder cancer remains limited. In Belgium, for instance, an important gap was observed between the…
Read more